Stability of Essential Drugs in Tropical Climates: Zimbabwe - EDM Research Series No. 013: Abbreviations

Table des matières

Abbreviations
1. Summary
2. Introduction
	2.1 Quality of pharmaceuticals in developing countries
	2.2 Background to the Zimbabwe stability study
	2.3 Research questions
	2.4 Acknowledgments
3. Study design and methods
	3.1 Outline of the study
	3.2 Sampling procedures
	3.3 Number and type of samples obtained
	3.4 Risk factors for poor drug quality
	3.5 Sample storage and laboratory tests
	3.6 Data processing and statistical analysis
4. Results
5. Discussion
	5.1 Drugs without failures
	5.2 Drugs with a low rate of failures
	5.3 Drugs with a high rate of failures
	5.4 Assumptions and limitations of data
	5.5 Pipeline times, expiry and shelf-life considerations
6. Conclusions and recommendations
	6.1 Initial quality of drugs
	6.2 Stability of drugs
	6.3 Factors influencing the quality of drugs
	6.4 Outcome of the study
	6.5 Practical recommendations for a quality assurance system
References
Annexes
	Annex 1: Detailed results for each drug
		1.1 Amoxycillin capsules
		1.2 Ampicillin capsules
		1.3 Acetylsalicylic acid tablets
		1.4 Doxycycline capsules
		1.5 Ferrous sulfate tablets
		1.6 Phenoxymethylpenicillin tablets
		1.7 Tetracycline capsules
		1.8 Retinol tablets
		1.9 Epinephrine injection
		1.10 Ampicillin injection
		1.11 Benzylpenicillin injection
		1.12 Ergometrine injection
		1.13 Procaine penicillin injection
	Annex 2: Validation of laboratory results

Abbreviations

BP	British Pharmacopoeia
CL	Confidence Limit
CMS	Government Medical Stores
MOHCW	Ministry of Health and Child Welfare
PHC	Primary Health Care
WHO	World Health Organization
ZEDAP	Zimbabwe Essential Drugs Action Programme
ZRDCL	Zimbabwe Regional Drug Quality Control Laboratory